| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |